Trichostatin A alleviated ovarian tissue damage caused by cigarette smoke exposure

Fang Li1, Jingjing Ding1, Yanfei Cong1

  • 1Department of Obstetrics and Gynecology, Shengjing Hospital, China Medical University, Shenyang, 110004, China; Medical Research Center of Shengjing Hospital, China Medical University, Shenyang, 110004, China; Key Laboratory of Research and Application of Animal Model for Environmental and Metabolic Diseases, Liaoning Province, China.

Insights

Cigarette smoke damages ovarian tissue by altering histone deacetylases 1 and 2 (HDAC1/2). Trichostatin A (TSA) protects against this damage by inhibiting HDAC1/2, restoring autophagy, and reducing pyroptosis.

Area of Science:

  • Reproductive Biology
  • Toxicology
  • Molecular Biology

Background:

  • Cigarette smoke (CS) adversely affects female fertility and reproductive health.
  • Histone deacetylases 1 and 2 (HDAC1/2) are implicated in oocyte development.
  • The specific roles of HDAC1/2 in CS-induced ovarian toxicity and the therapeutic effects of HDAC inhibitors like trichostatin A (TSA) remain unexplored.

Purpose of the Study:

  • To investigate the role of HDAC1/2 in cigarette smoke-induced ovarian toxicity.
  • To evaluate the therapeutic potential of trichostatin A (TSA) in mitigating CS-induced ovarian damage.
  • To elucidate the molecular mechanisms underlying TSA's protective effects, focusing on autophagy and pyroptosis.

Main Methods:

  • Female mice were exposed to CS twice daily for 30 days.
  • Mice received intraperitoneal injections of TSA (0.6 mg/kg) every two days.
  • Ovarian tissues were analyzed for structural changes, HDAC1/2 expression, autophagy markers, and pyroptosis indicators.

Main Results:

  • CS exposure led to ovarian tissue damage and increased expression of HDAC1/2.
  • TSA treatment alleviated CS-induced structural damage and prevented HDAC1/2 activation.
  • CS inhibited autophagy and activated pyroptosis, while TSA treatment reversed these effects.

Conclusions:

  • CS exposure causes ovarian toxicity through HDAC1/2 over-expression, autophagy inhibition, and pyroptosis activation.
  • TSA demonstrates therapeutic potential by alleviating CS-induced ovarian damage.
  • TSA's protective effects are likely mediated by the inhibition of HDAC1/2, impacting autophagy and pyroptosis pathways.